Z-SYMBOLS

Tesla shocks Wall Street with size of quarterly sales drop

Tesla shocks Wall Street with size of quarterly sales drop

Today, Tesla (TSLA) reported that it delivered just 386,810 vehicles in the first three months of the year. That was the biggest difference between actual sales and Wall Street sales estimates in data going back seven years, according to Bloomberg. Most analysts expected Tesla to sell more vehicles than a year ago. Instead, deliveries ended up dropping 8.5% year-over-year. And it was the first drop in year-over-year sales since the first year of the Covid-19 pandemic.

Special Report It’s a New World for Dividend Income Investors Pick #5 Visa

Special Report It’s a New World for Dividend Income Investors Pick #5 Visa

Bookkeeping. I added Visa as Pick #5 for my New World of Dividend Investors Special Report (You can find it in the Special Report section of this site along with all the content on this market and its trends for Dividend Income investors. But I’m reposting it as a stand alone pick so no one misses it.

Apple shareholders looking at an even more volatile six months–buy, sell, or hold (and when)

Apple shareholders looking at an even more volatile six months–buy, sell, or hold (and when)

Apple is likely to take its shareholders on an even wilder ride in the next six months than they’ve been on since the December all-time high at $199.62. The end result, I think is likely to be a renewed rally beginning in the fall–if you can either hold on through the volatility until then or see your way clear to timing when to buy and sell.

Counter-counter-attack from Viking Therapeutics in the GLP-1 diabetes/weight loss drug war

Counter-counter-attack from Viking Therapeutics in the GLP-1 diabetes/weight loss drug war

First, it was Viking Therapeutics (VKTX) on the attack with trial results that shows its GLP-1 dibetes/weight loss drug out performing current leader of the pack drugs fro Novo Nordisk (NVO) and Eli Lilly (LLY). On the news Viking soared.

Then Novo Nordisk struct back with data of its own showing progress on an oral formulation of its rugs. (All existing GLP-1 drugs are delivered by injection.) That cratered Viking Shares. Now, March 26, Viking has released new Phase 1 trial data from a multiple ascending dose study of the oral version of VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.

Please Watch My New YouTube Video: Quick Pick Digital Realty Trust

Please Watch My New YouTube Video: Quick Pick Digital Realty Trust

Today’s Quick Pick is Digital Realty Trust (DLR). This dividend stock, currently pays at 3.46% (previously a bit higher) but the stock has done well on price appreciation too. This is a different way to play the AI boom–by investing in the data center realty space. Data centers are the hottest part of the real estate market at the moment and AI data center capacity is likely to double in the next 6-10 years. Digital Realty has about 300 data centers worldwide with 40 million square feet of rentable space. They recently made a deal with Brookfield in order to raise more capital to build out more facilities and expand their business. The stock is up only about 5.6% year to date which isn’t great if you’re looking at the AI boom. It is up 43% over the last year but recent guidance from the company disappointed investors. The “meh” stock performance recently marks a good time to get in on a stock that has good dividends and a potential for capital appreciation when growth picks up again. The stock has been a member of my Dividend Portfolio since March 16, 2019. The shares are up 161% since then as of March 25. 

Special Report: It’s a new world for dividend income investors: 3 trends (all now posted) and 10 picks (now posted PFE, BEPC, NKE, EQNR, V, HON, T, VZ, RTX, ABBV)

Special Report: It’s a new world for dividend income investors: 3 trends (all now posted) and 10 picks (now posted PFE, BEPC, NKE, EQNR, V, HON, T, VZ, RTX, ABBV)

Let’s say you’re a dividend income investor. You need cash income in retirement. Or you want your portfolio to generate cash now so you can invest in new opportunities. Or you just want the extra safety and lower risk that owning a stock with a substantial dividend can bring. Whatever your reasons–and I can think of a lot more–this is a particularly challenging financial market for dividend income investors.But I do think there are strategies dividend income investors can successfully pursue even in this challenging market. In the rest of this Special Report I’m going to explain the three ways I think you should be thinking about dividend income investing in this market. And then I’m going to give you 10 dividend stocks that I think are especially well-suited to producing income (and price appreciation, which is always nice even if you’re an income investor) in this market environment. First pick just posted–Pfizer

Please Watch My New YouTube Video: Quick Pick Lithium Americas

Please Watch My New YouTube Video: Quick Pick Lithium Americas

Today’s Quick Pick is Lithium Americas (LAC). Lithium Americas is an American lithium producer, with a big deposit in Thacker Pass that has been going through litigation and delays while struggling to get enough financing with lithium prices down. We’ll likely see a bottom of lithium prices in the second half of 2024 or early 2025, so this is a good time to be getting in near the bottom. Lithium Americas signed a contract with General Motors agreeing that GM would take all the lithium they can produce, the question is, Can they produce it? Recently, the Department of Energy announced they’ll be lending Lithium Americas $2.3 billion to move forward with their processing facility. At the moment, China controls nearly all of the processing facilities for lithium globally and this investment will allow for domestic processing. This loan will cover all their capital costs and enable them to start production. The stock is moving upward, with shares around $6.50 per share. The recent rally has brought the stock back up to the price from December 2023, and the Wall Street consensus is that the stock may hit $11.50 in a year. While that prediction may be a bit ambitious, I think it’s likely we’ll see it reach $9-10, up about a third once they start to actually produce lithium in conjunction with lithium prices going up.